AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Angiotensin AT(4) receptors in the normal human prostate and benign prostatic hyperplasia
Authors: Dinh, DT Frauman, AG Casley, DJ Johnston, CI Fabiani, ME
Citation: Dt. Dinh et al., Angiotensin AT(4) receptors in the normal human prostate and benign prostatic hyperplasia, MOL C ENDOC, 184(1-2), 2001, pp. 187-192
In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat
Authors: Hubner, RA Kubota, E Casley, DJ Johnston, CI Burrell, LM
Citation: Ra. Hubner et al., In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat, J HYPERTENS, 19(5), 2001, pp. 941-946
Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat
Authors: Black, MJ Bertram, JF Johnston, CI
Citation: Mj. Black et al., Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat, J HYPERTENS, 19(4), 2001, pp. 785-794
Angiotensin receptors: distribution, signalling and function
Authors: Dinh, DT Frauman, AG Johnston, CI Fabiani, ME
Citation: Dt. Dinh et al., Angiotensin receptors: distribution, signalling and function, CLIN SCI, 100(5), 2001, pp. 481-492
Effect of angiotensin-converting enzyme inhibition on renal filtration surface area in hypertensive rats
Authors: Black, MJ Briscoe, TA Dunstan, HJ Bertram, JF Johnston, CI
Citation: Mj. Black et al., Effect of angiotensin-converting enzyme inhibition on renal filtration surface area in hypertensive rats, KIDNEY INT, 60(5), 2001, pp. 1837-1843
Chronic heart failure in Australian general practice - The Cardiac Awareness Survey and Evaluation (CASE) Study
Authors: Krum, H Tonkin, AM Currie, R Djundjek, R Johnston, CI
Citation: H. Krum et al., Chronic heart failure in Australian general practice - The Cardiac Awareness Survey and Evaluation (CASE) Study, MED J AUST, 174(9), 2001, pp. 439-444
Internal medicine
Authors: Johnston, CI Cooper, ME Taylor, AJ Shaw, JA
Citation: Ci. Johnston et al., Internal medicine, MED J AUST, 174(1), 2001, pp. 9-11
Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia
Authors: Nassis, L Frauman, AG Ohishi, M Zhuo, JL Casley, DJ Johnston, CI Fabiani, ME
Citation: L. Nassis et al., Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia, J PATHOLOGY, 195(5), 2001, pp. 571-579
Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia
Authors: Fabiani, ME Sourial, M Thomas, WG Johnston, CI Frauman, AG
Citation: Me. Fabiani et al., Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia, J ENDOCR, 171(1), 2001, pp. 97-108
Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia
Authors: Dinh, DT Frauman, AG Sourial, M Casley, DJ Johnston, CI Fabiani, ME
Citation: Dt. Dinh et al., Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia, ENDOCRINOL, 142(3), 2001, pp. 1349-1356
Vasopressin receptor antagonism - a therapeutic option in heart failure and hypertension
Authors: Burrell, LM Risvanis, J Johnston, CI Naitoh, M Balding, LC
Citation: Lm. Burrell et al., Vasopressin receptor antagonism - a therapeutic option in heart failure and hypertension, EXP PHYSIOL, 85, 2000, pp. 259S-265S
In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: A comparison with losartan
Authors: Fabiani, ME Dinh, DT Nassis, L Casley, DJ Johnston, CI
Citation: Me. Fabiani et al., In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: A comparison with losartan, AM J HYPERT, 13(9), 2000, pp. 1005-1013
Antihypertensive and antihypertrophic effects of omapatrilat in SHR
Authors: Burrell, LM Droogh, J in't Veld, OM Rockell, MD Farina, NK Johnston, CI
Citation: Lm. Burrell et al., Antihypertensive and antihypertrophic effects of omapatrilat in SHR, AM J HYPERT, 13(10), 2000, pp. 1110-1116
Angiotensin II type 1 receptor blockade: a novel therapeutic concept
Authors: Johnston, CI
Citation: Ci. Johnston, Angiotensin II type 1 receptor blockade: a novel therapeutic concept, BLOOD PRESS, 9, 2000, pp. 9-13
Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs
Authors: Farina, NK Johnston, CI Burrell, LM
Citation: Nk. Farina et al., Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs, J HYPERTENS, 18(6), 2000, pp. 749-755
Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure
Authors: Burrell, LM Farina, NK Balding, LC Johnston, CI
Citation: Lm. Burrell et al., Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure, HYPERTENSIO, 36(6), 2000, pp. 1105-1111
Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration
Authors: Fabiani, ME Dinh, DT Nassis, L Casley, DJ Johnston, CI
Citation: Me. Fabiani et al., Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration, CLIN SCI, 99(4), 2000, pp. 331-341
Optimizing treatment of hypertension in patients with diabetes
Authors: Cooper, ME Johnston, CI
Citation: Me. Cooper et Ci. Johnston, Optimizing treatment of hypertension in patients with diabetes, J AM MED A, 283(24), 2000, pp. 3177-3179
Clinical trials of ACE inhibitors: Pathogenetic insights and therapeutic advances
Authors: Burrell, LM Johnston, CI
Citation: Lm. Burrell et Ci. Johnston, Clinical trials of ACE inhibitors: Pathogenetic insights and therapeutic advances, V CH MO CAR, 1, 2000, pp. 191-200
JAMA and editorial independence
Authors: Glass, RM Fontanarosa, PB Rennie, D Winker, MA Southgate, MT Clayman, CB Cole, HM Cole, TB Cooper, DS Mark, DH Meyer, HS Olson, CM Siegel, RH Smith, JM Zylke, JW Clark, RA Cook, DJ Vaisrub, N Flanagin, A Breedlove, C Young, RK Jefferseon, TC Silberg, WM Goldsmith, M Iverson, C Williams, E Albert, DM Arndt, KA Barchas, JD Bowman, MA Dalen, JE DeAngelis, CD Johns, ME Larrabee, WF Organ, CH Rosenberg, RN Banta, HD Berger, M Blendon, RJ Chalmers, I DeBakey, L Evens, RG Johnston, CI Lindberg, DAB Maisonneuve, H Naylor, CD Pellegrino, ED Pyeritz, RE Reinhardt, UE Riis, P Roper, WL Terada, M
Citation: Rm. Glass et al., JAMA and editorial independence, ARCH PED AD, 153(3), 1999, pp. 221-222
JAMA and editorial independence (Reprinted from JAMA, vol 281, pg 460, 1999)
Authors: Glass, RM Fontanarosa, PB Rennie, D Winker, MA Southgate, MT Clayman, CB Cole, HM Cole, TB Cooper, DS Mark, DH Meyer, HS Olson, CM Siegel, RH Smith, JM Zylke, JW Clark, RA Cook, DJ Vaisrub, N Flanagin, A Breedlove, C Young, RK Jefferson, TC Silberg, WM Goldsmith, M Iverson, C Williams, E Albert, DM Arndt, KA Barchas, JD Bowman, MA Dalen, JE DeAngelis, CD Johns, ME Larrabee, WF Organ, CH Rosenberg, RN Banta, HD Berger, M Blendon, RJ Chalmers, I DeBakey, L Evens, RG Johnston, CI Lindberg, DAB Maisonneuve, H Naylor, CD Pellegrino, ED Pyeritz, RE Reinhardt, UE Riis, P Roper, WL Terada, M
Citation: Rm. Glass et al., JAMA and editorial independence (Reprinted from JAMA, vol 281, pg 460, 1999), ARCH OTOLAR, 125(3), 1999, pp. 259-260
Genomic characterization of the sheep vasopressin V1a receptor gene and promoter, with assignment to bands q23-24 of sheep chromosome 3 and cattle chromosome 5
Authors: Koukoulas, I Webb, GC Bottema, CDK Gill, C Johnston, CI Aldred, GP
Citation: I. Koukoulas et al., Genomic characterization of the sheep vasopressin V1a receptor gene and promoter, with assignment to bands q23-24 of sheep chromosome 3 and cattle chromosome 5, GENE, 240(1), 1999, pp. 183-192
JAMA and editorial independence
Authors: Glass, RM Fontanarosa, PB Rennie, D Winker, MA Southgate, MT Clayman, CB Cole, HM Cole, TB Cooper, DS Mark, DH Meyer, HS Olson, CM Siegel, RH Smith, JM Zylke, JW Clark, RA Cook, DJ Vaisrub, N Flanagin, A Breedlove, C Young, RK Jefferson, TC Silberg, WM Goldsmith, M Iverson, C Williams, E Banta, HD Berger, M Blendon, RJ Chalmers, I DeBakey, L Evens, RG Johnston, CI Lindberg, DAB Maisonneuve, H Naylor, CD Pellegrino, ED Pyeritz, RE Reinhardt, UE Riis, P Roper, WL Terada, M
Citation: Rm. Glass et al., JAMA and editorial independence, J AM MED A, 281(5), 1999, pp. 460-460
The effectiveness of a directly mailed smoking cessation intervention to Australian discharged hospital patients
Authors: Schofield, PE Hill, DJ Johnston, CI Streeton, JA
Citation: Pe. Schofield et al., The effectiveness of a directly mailed smoking cessation intervention to Australian discharged hospital patients, PREV MED, 29(6), 1999, pp. 527-534
In vivo and in vitro characterisation of a nonpeptide vasopressin V-1A andV-2 receptor antagonist (YM087) in the rat
Authors: Risvanis, J Naitoh, M Johnston, CI Burrell, LM
Citation: J. Risvanis et al., In vivo and in vitro characterisation of a nonpeptide vasopressin V-1A andV-2 receptor antagonist (YM087) in the rat, EUR J PHARM, 381(1), 1999, pp. 23-30
Risultati: 1-25 | 26-31